Josie Sandercock

2.2k total citations
28 papers, 1.5k citations indexed

About

Josie Sandercock is a scholar working on Hematology, Critical Care and Intensive Care Medicine and Emergency Medicine. According to data from OpenAlex, Josie Sandercock has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Critical Care and Intensive Care Medicine and 4 papers in Emergency Medicine. Recurrent topics in Josie Sandercock's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (5 papers), Blood transfusion and management (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Josie Sandercock is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (5 papers), Blood transfusion and management (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Josie Sandercock collaborates with scholars based in United Kingdom, United States and Italy. Josie Sandercock's co-authors include Susan Bayliss, Janine Dretzke, Chris Hyde, Amanda Burls, Emma Frew, Rod S Taylor, Julia Bohlius, Jayne S. Wilson, Carole Cummins and Sarah Stewart‐Brown and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Josie Sandercock

27 papers receiving 1.4k citations

Peers

Josie Sandercock
Eva P. Lester United Kingdom
Rodney Presley United States
John Miller United States
Andreas M. Pleil United States
Mark L. Robbins United States
Patricia Harrison United States
Josie Sandercock
Citations per year, relative to Josie Sandercock Josie Sandercock (= 1×) peers R. Nordhagen

Countries citing papers authored by Josie Sandercock

Since Specialization
Citations

This map shows the geographic impact of Josie Sandercock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josie Sandercock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josie Sandercock more than expected).

Fields of papers citing papers by Josie Sandercock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josie Sandercock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josie Sandercock. The network helps show where Josie Sandercock may publish in the future.

Co-authorship network of co-authors of Josie Sandercock

This figure shows the co-authorship network connecting the top 25 collaborators of Josie Sandercock. A scholar is included among the top collaborators of Josie Sandercock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josie Sandercock. Josie Sandercock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tingle, Samuel J, Georgios Kourounis, Felix Liu, et al.. (2024). Simple tool implementing Bucher’s method for indirect treatment comparisons in meta-analyses. BMJ evidence-based medicine. 30(2). 130–133. 2 indexed citations
2.
Cain, Lorna, Louise Geneen, Michael Wiltshire, et al.. (2024). Universal irradiation of platelets: Does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?. Transfusion Medicine Reviews. 38(4). 150840–150840. 1 indexed citations
4.
Wood, Erica M., Jake Shortt, Susan J Brunskill, et al.. (2023). Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review. Blood Reviews. 61. 101114–101114. 2 indexed citations
5.
Beverly, Anair, Catherine Kimber, Josie Sandercock, et al.. (2023). Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. 2023(2). CD013649–CD013649. 11 indexed citations
6.
McCullagh, Josephine, Rebecca Cardigan, Susan J Brunskill, et al.. (2022). Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review. Blood Reviews. 56. 100989–100989. 10 indexed citations
7.
Abdel‐Rahman, Manar E., J. Butler, Matthew R. Sydes, et al.. (2014). No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. British Journal of Cancer. 111(3). 589–597. 13 indexed citations
8.
Dretzke, Janine, Clare Davenport, Emma Frew, et al.. (2009). The clinical effectiveness of different parenting programmes for children with conduct problems: a systematic review of randomised controlled trials. Child and Adolescent Psychiatry and Mental Health. 3(1). 7–7. 237 indexed citations
9.
Cummins, Carole, et al.. (2008). Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. Health Technology Assessment. 12(36). iii, ix–x, 1. 125 indexed citations
10.
Wilson, Jayne S., Guiqing Yao, James Raftery, et al.. (2007). A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technology Assessment. 11(13). 1–202, iii. 135 indexed citations
11.
Frew, Emma, Josie Sandercock, William Whitehouse, & Stirling Bryan. (2006). The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies. Seizure. 16(2). 99–112. 9 indexed citations
12.
Bohlius, Julia, Jayne S. Wilson, Jerome Seidenfeld, et al.. (2006). Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients. JNCI Journal of the National Cancer Institute. 98(10). 708–714. 392 indexed citations
13.
Connock, Martin, Emma Frew, Stirling Bryan, et al.. (2006). The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review. Health Technology Assessment. 10(7). iii, ix–118. 32 indexed citations
14.
Sandercock, Josie & Edward W. Said. (2004). Peace under fire : Israel/Palestine and the International Solidarity Movement. 15 indexed citations
15.
Dretzke, Janine, Carole Cummins, Josie Sandercock, et al.. (2004). Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. Health Technology Assessment. 8(22). iii–xi, 1. 74 indexed citations
17.
Sandercock, Josie, M.K.B. Parmar, Valter Torri, & W. Qian. (2002). First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence. British Journal of Cancer. 87(8). 815–824. 86 indexed citations
18.
Stewart, Antony, Josie Sandercock, Stirling Bryan, et al.. (2001). The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technology Assessment. 5(2). 1–97. 64 indexed citations
19.
Piccart, Martine, William P. McGuire, Martin Gore, et al.. (1999). ICON2 trial (multiple letter) [1]. The Lancet. 353(9152). 587–588.
20.
Sandercock, Josie, et al.. (1998). First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence. British Journal of Cancer. 78(11). 1471–1478. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026